Patients who stop using weight loss medications are likely to return to their baseline weight within two years, a new ...

In an abrupt and surprising twist, the CEO of Ozempic-maker Novo Nordisk has been ousted from his position as the head of the ...

Two in three adults could be obese by 2050, according to world heart report (EMB Sat 17th 00:00) - More than 800 million ...